Mission statement · Company scope
“Our mission is to maximize the clinical and commercial potential of cabozantinib, and to position us for future growth through our discovery efforts and expansion of our development pipeline.”
In use2019 – now1 sighting
First seenFeb 2019Added
Last seenFeb 2019Latest observation
Date created—Not published by the organization
Record
- Kind
- Mission
- Scope
- Company
- Style
- Innovation (primary)
- Leads with
- Invention
- Best for
- Climate & health
- Formula
- We’re building [new thing] so [result]
- Tone
- Aspirational
- Length
- 29 words · reading grade 18.5
- Review status
- unreviewed · classifier rules-v0
- Quality score
- 0.75
- Record
- st_77dfaca18baee151
- Classification confidence
- 0.75
Sources1 sighting
SEC
SEC EDGAR filingsObserved 2019-02-22 · sec_sentence · 10-K · accession 0000939767-19-000042
View filing ↗0 to compareCompare